ISRCTN52781697已完成不适用
Evaluation of topical ciclosporin A in prevention of corneal graft rejection: a randomised double blind single centre study
Indian Council of Medical Research (ICMR) (India)0 个研究点目标入组 84 人开始时间: 2009年9月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients greater than or equal to 9 years of age, either sex
- •2. Eyes undergoing penetrating keratoplasty
- •3. With two or more quadrants of corneal vascularisation extending at least 2 mm into the cornea
- •4. Cases of corneal re-grafts
排除标准
- •1. Grafts that are not high-risk
- •2. Pregnant/lactating females
- •3. Children below 9 years of age
- •4. Patients who refused to give consent
研究者
相似试验
终止
4 期
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry EyeDry EyeNCT00553735Massachusetts Eye and Ear Infirmary8
已完成
不适用
nderstanding the role of Cyclosporin A drops in control of ocular inflammation in acute cases of Stevens Johnson SyndromeAcute Stevens-Johnson SyndromeSkin and Connective Tissue DiseasesStevens-Johnson syndromeISRCTN11036223All India Institute of Medical Sciences60
已完成
4 期
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseasePrimary Sjogren SyndromeSecondary Sjogren SyndromeAqueous Deficient Dry Eye DiseaseEvaporative Dry Eye DiseaseNCT02004067Federal University of São Paulo100
招募中
3 期
Topical cyclosporine 0.05% impact on pterygium recurrence in patients undergoing pterygium surgeryIRCT20160919029871N4Guilan University Of Medical Sciences74
已完成
4 期
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaPterygiaNCT00383396Innovative Medical